INDO US BIO-TECH | MONSANTO INDIA | INDO US BIO-TECH/ MONSANTO INDIA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 42.6 | 23.8 | 179.3% | View Chart |
P/BV | x | 8.0 | 5.4 | 146.7% | View Chart |
Dividend Yield | % | 0.0 | 2.2 | - |
INDO US BIO-TECH MONSANTO INDIA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
INDO US BIO-TECH Mar-24 |
MONSANTO INDIA Mar-19 |
INDO US BIO-TECH/ MONSANTO INDIA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 304 | 3,358 | 9.1% | |
Low | Rs | 90 | 2,424 | 3.7% | |
Sales per share (Unadj.) | Rs | 36.3 | 387.9 | 9.4% | |
Earnings per share (Unadj.) | Rs | 4.1 | 87.9 | 4.7% | |
Cash flow per share (Unadj.) | Rs | 4.5 | 94.7 | 4.8% | |
Dividends per share (Unadj.) | Rs | 0 | 50.00 | 0.0% | |
Avg Dividend yield | % | 0 | 1.7 | 0.0% | |
Book value per share (Unadj.) | Rs | 31.3 | 409.6 | 7.6% | |
Shares outstanding (eoy) | m | 20.05 | 17.26 | 116.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 5.4 | 7.5 | 72.8% | |
Avg P/E ratio | x | 47.9 | 32.9 | 145.5% | |
P/CF ratio (eoy) | x | 43.6 | 30.5 | 142.9% | |
Price / Book Value ratio | x | 6.3 | 7.1 | 89.2% | |
Dividend payout | % | 0 | 56.9 | 0.0% | |
Avg Mkt Cap | Rs m | 3,951 | 49,907 | 7.9% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 9 | 511 | 1.8% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 728 | 6,696 | 10.9% | |
Other income | Rs m | 3 | 225 | 1.4% | |
Total revenues | Rs m | 732 | 6,921 | 10.6% | |
Gross profit | Rs m | 108 | 1,591 | 6.8% | |
Depreciation | Rs m | 8 | 118 | 6.8% | |
Interest | Rs m | 15 | 11 | 134.4% | |
Profit before tax | Rs m | 88 | 1,687 | 5.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 6 | 170 | 3.2% | |
Profit after tax | Rs m | 83 | 1,517 | 5.4% | |
Gross profit margin | % | 14.8 | 23.8 | 62.4% | |
Effective tax rate | % | 6.3 | 10.1 | 62.3% | |
Net profit margin | % | 11.3 | 22.7 | 50.0% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 731 | 7,068 | 10.3% | |
Current liabilities | Rs m | 175 | 2,989 | 5.8% | |
Net working cap to sales | % | 76.4 | 60.9 | 125.4% | |
Current ratio | x | 4.2 | 2.4 | 177.0% | |
Inventory Days | Days | 1 | 318 | 0.4% | |
Debtors Days | Days | 95,439,526 | 6 | 1,682,172,772.2% | |
Net fixed assets | Rs m | 107 | 4,700 | 2.3% | |
Share capital | Rs m | 201 | 173 | 116.2% | |
"Free" reserves | Rs m | 427 | 6,896 | 6.2% | |
Net worth | Rs m | 627 | 7,069 | 8.9% | |
Long term debt | Rs m | 28 | 0 | - | |
Total assets | Rs m | 838 | 11,768 | 7.1% | |
Interest coverage | x | 6.8 | 150.3 | 4.5% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.9 | 0.6 | 152.8% | |
Return on assets | % | 11.7 | 13.0 | 89.8% | |
Return on equity | % | 13.2 | 21.5 | 61.3% | |
Return on capital | % | 15.7 | 24.0 | 65.6% | |
Exports to sales | % | 0 | 8.3 | 0.0% | |
Imports to sales | % | 0 | 19.0 | 0.0% | |
Exports (fob) | Rs m | NA | 554 | 0.0% | |
Imports (cif) | Rs m | NA | 1,273 | 0.0% | |
Fx inflow | Rs m | 0 | 554 | 0.0% | |
Fx outflow | Rs m | 0 | 1,430 | 0.0% | |
Net fx | Rs m | 0 | -876 | -0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -46 | 141 | -32.4% | |
From Investments | Rs m | 43 | 709 | 6.0% | |
From Financial Activity | Rs m | 12 | -831 | -1.5% | |
Net Cashflow | Rs m | 9 | 19 | 48.4% |
Indian Promoters | % | 70.2 | 0.0 | - | |
Foreign collaborators | % | 0.0 | 81.8 | - | |
Indian inst/Mut Fund | % | 0.0 | 2.4 | - | |
FIIs | % | 0.0 | 2.2 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 29.8 | 18.2 | 164.3% | |
Shareholders | 973 | 20,208 | 4.8% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare INDO US BIO-TECH With: KAVERI SEED VENKYS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | INDO US BIO-TECH | MONSANTO INDIA |
---|---|---|
1-Day | -1.42% | -0.46% |
1-Month | -0.82% | 11.62% |
1-Year | 34.47% | -22.26% |
3-Year CAGR | 79.07% | -2.65% |
5-Year CAGR | 54.26% | -6.18% |
* Compound Annual Growth Rate
Here are more details on the INDO US BIO-TECH share price and the MONSANTO INDIA share price.
Moving on to shareholding structures...
The promoters of INDO US BIO-TECH hold a 70.2% stake in the company. In case of MONSANTO INDIA the stake stands at 81.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of INDO US BIO-TECH and the shareholding pattern of MONSANTO INDIA.
Finally, a word on dividends...
In the most recent financial year, INDO US BIO-TECH paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
MONSANTO INDIA paid Rs 50.0, and its dividend payout ratio stood at 56.9%.
You may visit here to review the dividend history of INDO US BIO-TECH, and the dividend history of MONSANTO INDIA.
After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.